EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Evaluation of Olaparib Tablet Safety and Pharmacokinetics in Healthy Chinese Male Subjects

Ruihua Dong, Jingcheng Chen, Nini Guo iD, Yingying Yang, Jingxuan Wu, Xiaoru Wang, Yuqin Song, Xueyuan Zhang

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s481481 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Ruihua Dong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Phase I Clinical Trial Laboratory, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Phthalazines, Piperazines. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhthalazinesPiperazinesAdultHumansMaleYoung AdultAdministration, OralArea Under CurveCross-Over StudiesDose-Response Relationship, DrugEast Asian PeopleHealthy VolunteersTablets

Stichwörter der Autor:innen

bioequivalencehealthy Chinese male subjectsolaparibpharmacokineticssafety

Substanzen

olaparibPhthalazinesPiperazinesTablets

Autor:innen und Institutionen

  • Phase I Clinical Trial Laboratory, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Clinical Department, CSPC Zhongqi Pharmaceutical Technology (SJZ) Co., LTD., Shijiazhuang, Hebei Province, People's Republic of China.

ORCID-Profile: Nini Guo

Zitieren

APA

Dong, R., Chen, J., Guo, N., Yang, Y., Wu, J., Wang, X., Song, Y., & Zhang, X. (2024). Evaluation of Olaparib Tablet Safety and Pharmacokinetics in Healthy Chinese Male Subjects. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s481481

Vancouver

Dong R, Chen J, Guo N, Yang Y, Wu J, Wang X, et al. Evaluation of Olaparib Tablet Safety and Pharmacokinetics in Healthy Chinese Male Subjects. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s481481

BibTeX
@article{Dong2024,
  author = {Dong, Ruihua and Chen, Jingcheng and Guo, Nini and Yang, Yingying and Wu, Jingxuan and Wang, Xiaoru and Song, Yuqin and Zhang, Xueyuan},
  title = {Evaluation of Olaparib Tablet Safety and Pharmacokinetics in Healthy Chinese Male Subjects},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s481481}
}
Kostenlos starten →